What Is HIPEC? Benefits, Risks and Eligibility

01 / PATIENT GUIDE

Heated Chemotherapy Inside the Abdomen

HIPEC stands for hyperthermic intraperitoneal chemotherapy. Heated chemotherapy circulates inside the abdomen to target cancer cells on the peritoneum—the lining of the abdominal cavity.

HIPEC is often discussed alongside cytoreductive surgery (CRS), which aims to remove visible cancer. Whether HIPEC belongs in your treatment plan depends on your diagnosis, disease extent and overall health.

HIPEC is not suitable for everyone. Understanding why it may—or may not—be recommended is part of an informed assessment.

AI-generated educational illustrations throughout this guide. Anatomy and devices are simplified; scenes do not show actual clinicians, patients, hospitals or results.

Ask About an Assessment

Where does HIPEC act?

The peritoneum lines the abdominal cavity and covers many abdominal organs. HIPEC is a local treatment directed at this space.

How does the solution circulate?

Heated chemotherapy solution circulates through the abdominal cavity using a specialised system. This schematic shows the route, not a specific device or protocol.

02 / YOUR QUESTIONS

How Do HIPEC, CRS and IV Chemotherapy Differ?

These treatments have different roles. Your plan may include more than one approach.

CRS: remove visible disease

Cytoreductive surgery aims to remove visible cancer deposits. The possible extent of surgery and the likelihood of removing visible disease require careful assessment.

HIPEC: treat within the abdomen

HIPEC delivers heated chemotherapy into the abdominal cavity. Its potential role depends on the cancer and the specific protocol.

IV chemotherapy: systemic treatment

Intravenous chemotherapy travels through the bloodstream. It may be used before or after surgery, or without surgery. HIPEC does not automatically replace systemic treatment.

03 / YOUR QUESTIONS

Could HIPEC Be an Option for Me?

Peritoneal metastasis alone does not determine eligibility. Assessment considers both the cancer and your ability to tolerate treatment.

The key question: does the expected benefit justify the risks in your situation?

1. Confirm the cancer type

The cancer's origin and pathology help determine which evidence and treatments apply.

2. Map the disease

The team considers disease distribution inside and outside the abdomen. The Peritoneal Cancer Index (PCI) is one part of assessment, not a decision on its own.

3. Assess possible surgery

Where deposits sit, and their relationship to bowel and other structures, affect whether visible disease can be removed safely.

4. Review previous treatment

Previous surgery, medicines and treatment response help the team understand the options that remain.

5. Assess health and nutrition

Fitness, nutrition and organ function matter when estimating whether you can tolerate treatment and recovery.

6. Understand your priorities

Discuss the balance of possible benefit, recovery demands and quality of life in relation to what matters to you.

04 / YOUR QUESTIONS

What Benefits and Limitations Should I Understand?

There is no single HIPEC success rate that describes every patient. The additional benefit alongside surgery varies by cancer, patient selection and regimen.

The ASCO metastatic colorectal cancer guideline does not recommend adding oxaliplatin-based HIPEC to CRS for colorectal peritoneal metastases. Discuss the exact regimen being proposed.

Read the ASCO guideline

What is the treatment trying to achieve?

HIPEC aims to expose cancer cells on peritoneal surfaces to heated chemotherapy. Ask whether your proposed plan aims for long-term control, a possibility of cure, or another defined goal. No cure is guaranteed.

What does the evidence actually support?

An additional benefit is not established for every situation. Patient selection, cancer type, medicine and timing differ between studies; a result from one regimen cannot be assumed for another.

05 / YOUR QUESTIONS

What Happens from Assessment to Continuing Care?

An assessment does not mean that surgery or HIPEC will necessarily be recommended.

1. Review the diagnosis

Review pathology, imaging, previous treatment and current health. Ask which additional investigations, if any, are needed.

2. Compare the options

Discuss surgery, HIPEC, systemic treatment and other appropriate approaches. Clarify the goal and the evidence for each.

3. Agree on a plan

Discuss the possible extent of surgery, major risks and circumstances in which the plan might change.

4. Treatment, if recommended

In an intraoperative CRS–HIPEC approach, surgeons remove visible disease where feasible, then circulate heated chemotherapy in the abdomen. Drug, timing and duration vary by protocol.

5. Plan continuing care

Plan postoperative recovery, further cancer treatment and follow-up. Confirm the exact protocol: HIPEC is not identical across centres or studies.

06 / YOUR QUESTIONS

What Are the Risks and Recovery Needs?

CRS with HIPEC can involve major surgery and serious complications. Individual risk depends on the operation, drug regimen and your health.

Surgical risks: bleeding, infection, blood clots, bowel leakage or obstruction, and serious complications including death.
Drug-related risks: kidney injury, low blood cell counts, nausea and vomiting, and other effects depending on the medicine.

HIPEC risks — Mayo Clinic · Recovery guidance — University Hospitals Birmingham

Monitoring and symptom control

Ask how pain, bowel function and other postoperative concerns will be monitored and managed during the hospital stay.

Nutrition and eating

Ask how your nutritional needs will be assessed and supported. The food shown is illustrative; your plan depends on the operation and recovery.

Mobility and daily activities

Ask how walking and activity will progress with support. Returning to work, exercise and travel may happen at different times.

Support after discharge

Clarify caregiver support, wound or stoma care, warning symptoms and who to contact. Ask whether a temporary or permanent stoma could be needed.

07 / YOUR QUESTIONS

What If HIPEC Is Not Recommended?

Not being offered HIPEC does not mean there are no options. Another approach may offer a more appropriate balance of benefit and risk.

Ask what is recommended instead, why it is preferred and whether reassessment could be appropriate later.

Colorectal treatment options — American Cancer Society

Systemic treatment

Chemotherapy, targeted therapy or immunotherapy may be considered according to the cancer, molecular findings and treatment history.

Other surgical approaches

Surgery may have a different role, such as addressing a specific complication. Ask the team to explain its purpose and expected benefit.

Supportive care

Pain relief, nutrition and other symptom support can be provided alongside cancer treatment. Ask which services could help your daily life.

Clinical trials

Ask whether a suitable study is available, what participation involves and whether you meet its criteria. Availability varies.

08 / YOUR QUESTIONS

What Expertise and Research Inform Assessment?

Hui Wang is a chief physician at the Sixth Affiliated Hospital of Sun Yat-sen University. His clinical interests include colorectal cancer, peritoneal metastases and complex surgical conditions.

The images below illustrate concepts; they do not depict Hui Wang, his team, actual study participants or study data.

Official physician profile · Read the 2022 study

Relevant clinical expertise

Hui Wang's official hospital profile describes interests in colorectal cancer, peritoneal metastases and complex surgical conditions. This teaching model is illustrative, not evidence of a particular service or outcome.

What the 2022 study compared

A single-centre retrospective study compared CRS with and without HIPEC in 78 patients with isolated synchronous colorectal peritoneal metastases. It reported an association with better survival in the HIPEC group.

Why this cannot predict your result

The selected population, observational design and mainly postoperative 5-FU regimen limit generalisation. The study does not establish benefit for every HIPEC protocol or describe the provider's current protocol.

09 / YOUR QUESTIONS

What Should I Plan Before Travelling to China?

Before booking travel, clarify what can be reviewed in advance, whether an in-person visit is needed, and the expected costs and support.

An estimate does not guarantee eligibility. Medical assessment should guide treatment and travel decisions.

Prepare records securely

Ask about pathology reports, recent imaging and reports, operation records, treatment history and medicines. Confirm an appropriate secure sharing method before sending medical information.

Ask for an itemised estimate

Request a written estimate covering assessment, surgery, anaesthesia, chemotherapy and hospital care. Clarify exclusions and how complications or additional treatment might change costs.

Confirm travel arrangements

Confirm appointment availability, language support and caregiver needs before booking. Clarify accommodation, interpretation and travel costs separately.

Plan follow-up at home

Discuss continuing care with your doctor at home and who will answer concerns after discharge. Discharge readiness does not necessarily mean readiness for an international flight.

10 / YOUR QUESTIONS

What Should I Ask, and How Do I Start?

Contact medChina to ask about the assessment process. Treatment suitability must be determined by the treating medical team.

Prepare questions for your specialist

Why is this approach suitable? What benefit is realistic? What are the major risks and alternatives? How will recovery and follow-up be managed?

Start with a general enquiry

Ask medChina about the assessment process. Receiving provider, availability, fees and treatment eligibility require separate confirmation. An enquiry does not book treatment.

More Questions About HIPEC

These answers explain the process. Treatment decisions require individual clinical assessment.

Does an enquiry mean I am booking treatment?

Can a family member enquire?

Does research predict my result?

What should I ask a specialist?

Contact medChina

medchina.service@gmail.com

Read our Privacy Policy

This guide is for general education. Individual medical advice requires assessment by qualified clinicians. AI illustrations do not represent actual clinicians, patients or outcomes.

Enquire About a HIPEC Assessment

Leave your name, email and a general enquiry. You may include your country and preferred language. Please do not include medical records or sensitive health details in this initial message.

Availability, receiving provider and fees require separate confirmation. An enquiry does not book treatment or establish a doctor-patient relationship.